Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -364.82 Million MYR | -151.89% |
| 2022 | 703.02 Million MYR | -93.2% |
| 2021 | 10.33 Billion MYR | 323.93% |
| 2020 | 2.43 Billion MYR | 250.63% |
| 2019 | 695.5 Million MYR | -0.13% |
| 2018 | 647.83 Million MYR | 41.52% |
| 2017 | 428.38 Million MYR | -8.92% |
| 2016 | 540.23 Million MYR | 16.56% |
| 2015 | 434.88 Million MYR | 58.89% |
| 2014 | 265.36 Million MYR | -6.9% |
| 2013 | 276.18 Million MYR | 1.07% |
| 2012 | 310 Million MYR | 130.58% |
| 2011 | 134.44 Million MYR | -63.13% |
| 2010 | 364.66 Million MYR | 26.85% |
| 2009 | 287.48 Million MYR | 44.65% |
| 2008 | 197.84 Million MYR | 13.15% |
| 2007 | 175.65 Million MYR | 35.6% |
| 2006 | 129.53 Million MYR | 45.47% |
| 2005 | 89.04 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 32.87 Million MYR | 311.09% |
| 2024 Q1 | 17.81 Million MYR | 105.94% |
| 2024 Q2 | 11.2 Million MYR | 42.18% |
| 2023 Q3 | -18.19 Million MYR | 66.7% |
| 2023 Q2 | -54.64 Million MYR | 11.42% |
| 2023 FY | - MYR | -151.89% |
| 2023 Q1 | -61.69 Million MYR | -254.29% |
| 2023 Q4 | -230.74 Million MYR | -1168.15% |
| 2022 Q4 | 39.98 Million MYR | -68.86% |
| 2022 Q2 | 199.06 Million MYR | -42.05% |
| 2022 Q1 | 343.52 Million MYR | -50.85% |
| 2022 FY | - MYR | -93.2% |
| 2022 Q3 | 128.42 Million MYR | -35.48% |
| 2021 Q4 | 698.88 Million MYR | -73.96% |
| 2021 Q3 | 2.68 Billion MYR | -29.48% |
| 2021 Q2 | 3.8 Billion MYR | 20.17% |
| 2021 Q1 | 3.16 Billion MYR | 103.72% |
| 2021 FY | - MYR | 323.93% |
| 2020 Q3 | 487.01 Million MYR | 137.83% |
| 2020 Q4 | 1.55 Billion MYR | 219.29% |
| 2020 Q1 | 198.56 Million MYR | 37.66% |
| 2020 FY | - MYR | 250.63% |
| 2020 Q2 | 204.77 Million MYR | 3.13% |
| 2019 Q1 | 208.23 Million MYR | 1.23% |
| 2019 Q2 | 192.71 Million MYR | -7.46% |
| 2019 Q3 | 152.9 Million MYR | -20.65% |
| 2019 FY | - MYR | -0.13% |
| 2019 Q4 | 144.24 Million MYR | -5.67% |
| 2018 Q3 | 185.84 Million MYR | 16.25% |
| 2018 Q4 | 205.7 Million MYR | 10.69% |
| 2018 Q2 | 159.86 Million MYR | 3.19% |
| 2018 Q1 | 154.91 Million MYR | 18.25% |
| 2018 FY | - MYR | 41.52% |
| 2017 Q1 | 117.14 Million MYR | 12.92% |
| 2017 FY | - MYR | -8.92% |
| 2017 Q4 | 131.01 Million MYR | 7.7% |
| 2017 Q3 | 121.64 Million MYR | -7.45% |
| 2017 Q2 | 131.42 Million MYR | 12.19% |
| 2016 FY | - MYR | 16.56% |
| 2016 Q1 | 191.8 Million MYR | 18.73% |
| 2016 Q3 | 101.47 Million MYR | -36.66% |
| 2016 Q4 | 103.74 Million MYR | 2.23% |
| 2016 Q2 | 160.2 Million MYR | -16.48% |
| 2015 Q4 | 161.55 Million MYR | 27.27% |
| 2015 Q3 | 126.93 Million MYR | 34.03% |
| 2015 Q2 | 94.7 Million MYR | 13.69% |
| 2015 FY | - MYR | 58.89% |
| 2015 Q1 | 83.3 Million MYR | 10.68% |
| 2014 Q3 | 79.65 Million MYR | 8.65% |
| 2014 Q2 | 73.3 Million MYR | -13.11% |
| 2014 Q1 | 84.37 Million MYR | -3.65% |
| 2014 FY | - MYR | -6.9% |
| 2014 Q4 | 75.26 Million MYR | -5.51% |
| 2013 FY | - MYR | 1.07% |
| 2013 Q2 | 82.11 Million MYR | -8.38% |
| 2013 Q4 | 87.56 Million MYR | 36.87% |
| 2013 Q1 | 89.63 Million MYR | 5.48% |
| 2013 Q3 | 63.97 Million MYR | -22.09% |
| 2012 Q3 | 81.06 Million MYR | -5.49% |
| 2012 FY | - MYR | 130.58% |
| 2012 Q1 | 58.19 Million MYR | 145.82% |
| 2012 Q2 | 85.77 Million MYR | 47.41% |
| 2012 Q4 | 84.97 Million MYR | 4.82% |
| 2011 Q3 | 49.56 Million MYR | 57.21% |
| 2011 Q4 | 23.67 Million MYR | -52.24% |
| 2011 Q2 | 31.52 Million MYR | 0.0% |
| 2011 FY | - MYR | -63.13% |
| 2010 FY | - MYR | 26.85% |
| 2009 FY | - MYR | 44.65% |
| 2008 FY | - MYR | 13.15% |
| 2007 FY | - MYR | 35.6% |
| 2006 FY | - MYR | 45.47% |
| 2005 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -37746.308% |
| Ansell Limited | 209.86 Million USD | 273.839% |
| Ansell Limited | 206.3 Million USD | 276.84% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 951.594% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | -22351.2% |
| Psykey, Inc. | -1.29 Million USD | -28064.894% |
| ConvaTec Group Plc | 455.5 Million USD | 180.092% |
| ConvaTec Group Plc | 455.5 Million USD | 180.092% |
| Encision Inc. | -544.19 Thousand USD | -66938.653% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -257160.419% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -331766.642% |
| Innovative MedTech Inc. | -7.67 Million USD | -4654.101% |
| LifePoint, Inc. | -14.2 Million USD | -2468.775% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | -5796.573% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -112152.615% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -169399.707% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -89805.221% |
| SmileDirectClub, Inc. | -186.13 Million USD | -95.994% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 181.465% |
| SheerVision, Inc. | -110.53 Thousand USD | -329962.155% |
| United Health Products, Inc. | -2.5 Million USD | -14479.928% |
| Vasamed, Inc. | -4.57 Million USD | -7875.202% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | -16037.267% |
| Yubo International Biotech Limited | -1.17 Million USD | -30877.782% |